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One of the most significant challenges of cell biology is to understand how each type of
cell copes with its specific workload without suffering damage. Among the most intrigu-
ing questions concerns intestinal epithelial cells in mammals; these cells act as a barrier
between the internally protected region and the external environment that is exposed
constantly to food and microbes. A major process involved in the processing of microbes
is autophagy. In the intestine, through multiple, complex signaling pathways, autophagy
including macroautophagy and xenophagy is pivotal in mounting appropriate intestinal
immune responses and anti-microbial protection. Dysfunctional autophagy mechanism
leads to chronic intestinal inflammation, such as inflammatory bowel disease (IBD). Stud-
ies involving a number of in vitro and in vivo mouse models in addition to human clinical
studies have revealed a detailed role for autophagy in the generation of chronic intestinal
inflammation. A number of genome-wide association studies identified roles for numerous
autophagy genes in IBD, especially in Crohn’s disease. In this review, we will explore in
detail the latest research linking autophagy to intestinal homeostasis and how alterations
in autophagy pathways lead to intestinal inflammation.
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INTRODUCTION
Autophagy literally means “self-eating.” Autophagy describes a
process by which our cells are able to cope with damaged organelles
and malformed proteins by directing them to lysosomal degra-
dation. Autophagy may be divided into three classes; macroau-
tophagy, macroautophagy, and chaperone-mediated autophagy (1,
2). Of these three classes, macroautophagy, or simply autophagy,
as it will be referred to hereafter, is the most studied and is the
form implicated in the regulation of chronic inflammation and
is therefore the focus of this review. Induction of autophagy pro-
motes cell survival during nutrient deprivation, oxidative stress,
and endoplasmic reticulum (ER) stress, and is therefore criti-
cally important for the maintenance of cellular homeostasis (3–5).
Since autophagy involves the degradation of bulk cytoplasm it
is minimally active under normal conditions but may be read-
ily induced by a diverse range of intracellular stressors. It is now
evident that the mechanisms which target specific structures for
degradation are in fact quite selective. Selective degradation of
mitochondria (mitophagy), ribosomes (ribophagy), peroxisomes
(pexophagy), and ER has been reported (6–9). An additional
form of selective autophagy is xenophagy. Xenophagy serves to
degrade invasive pathogens in a specialized form of autophagy
termed xenophagy (10). Xenophagy involves the recruitment of
the autophagic machinery to degrade invasive viral or bacterial
pathogens. The myriad roles of autophagy in regulating homeosta-
sis make it of particular interest in study of the intestinal mucosa,
where all the aforementioned stresses are likely to converge.
The intestinal mucosa is constantly exposed to dietary and
microbial antigens. The intestinal epithelium and its associated
mucus layer serves as a physical barrier against the external
environment. However, in order to fulfill its function in the
absorption of nutrients a degree of permeability to the lumi-
nal contents is required. Naturally, not all antigens to which the
intestinal mucosa is exposed are pathogenic; the correct balance
between inflammation and tolerance is a complex mechanism that
involves hematopoietic and non-hematopoietic cells. A form of
intestinal homeostasis allowing the protection against pathogens
whilst tolerating food antigen and the beneficial, non-pathogenic
commensal microbes is required. The need to maintain intesti-
nal homeostasis has seen a number of complex signaling path-
ways evolve between a diverse range of cell types. Deficiencies
in this signaling network may result in a loss of homeostasis
and in the development of chronic inflammatory diseases such
as the inflammatory bowel diseases (IBD). Two chronic relaps-
ing and remitting disorders, namely Crohn’s disease (CD) and
ulcerative colitis (UC), constitute the majority of IBD cases.
Both of these conditions cause severe abdominal discomfort and
lead to significant morbidity and loss of quality of life. Cur-
rently no cure for IBD exists; the treatment of IBD involves the
alleviation of symptoms using anti-inflammatory agents such
as steroids and non-steroid anti-inflammatory drugs (NSAID).
Despite intensive research, the exact pathogenesis of IBD remains
elusive.
Recently, a number of studies, genome-wide association stud-
ies (GWAS) in particular, have identified a link between genes
involved in autophagy regulation and IBDs. Given its impor-
tance of autophagy as a regulator of cellular homeostasis and
of innate immunity, understanding the contribution of defective
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autophagy to the pathogenesis of chronic inflammation may be
of considerable value to human health. In this review, we aim to
initially discuss the general mechanisms of autophagy, and then
describe in detail the link between autophagy machinery and the
intestinal epithelium in gut homeostasis and inflammation.
AUTOPHAGY MECHANISMS
Although autophagy has been reported since the 1960s, detailed
description of the molecular mechanisms regulating autophagy
has only occurred relatively recently (11). We know now that
the autophagy pathway is reliant upon the proteins encoded by
autophagy-related genes (Atg), the first of which, Atg1, was iden-
tified 20 years ago in the yeast Saccharomyces cerevisiae (12). Since
then, over 30 Atg proteins and their functions have been identified
(13, 14). The autophagy-related genes essential for the assembly of
the autophagosome are highly conserved between yeasts, worms,
flies, and mammals. Such high degree of conservation is presum-
ably due to the importance autophagy in cell survival, therefore
much of our knowledge of autophagy mechanisms obtained from
yeast may be translated to mammalian cells. Several compre-
hensive reports detailing the current understanding molecular
mechanisms and regulation of autophagy in physiology and dis-
ease in both yeasts and mammals already exist in the literature
(15, 16). For the purpose of this review however, we will give a
brief overview of the proposed general mechanisms of mammalian
autophagy prior to describing the role of autophagy-regulating
genes in the pathogenesis of CD.
The defining feature of macroautophagy, as opposed to the
other classes of autophagy, is the formation of the double-
membrane vesicle known as the “autophagosome.” The process
of autophagy may be divided into several stages: induction, nucle-
ation, elongation, endosomal/lysosomal docking and fusion with
the autophagosome, and finally, degradation (Figure 1). The first
of these stages, the initiation of autophagy, may occur through
a range of signaling pathways, dependent upon the stimulus. The
mammalian target of rapamycin complex 1 (mTORC1) appears to
be the central regulator of autophagy induction. In nutrient-rich
conditions mTORC1 is active, and represses autophagosome for-
mation (Figure 2). Inactivation of mTORC1, e.g., by starvation,
results in the de-repression of signaling pathways downstream
of mTORC1 and results in initiation of autophagy. The impor-
tance of mTOR in autophagy stimulated by other stressors such
as certain invasive pathogens however, may be limited (17). Under
the control of mTORC1 is a complex composed of uncoordinated
51-like kinase 1 (ULK1; the mammalian ortholog of Atg1), Atg13,
Atg101, and focal adhesion kinase family interacting protein of
200 kDa (FIP200; Atg17 ortholog) (18–20). The ULK1-Atg13-
FIP200 complex is thought to be the earliest factor recruited to
the autophagosome precursor. Repression of mTORC1 results in
phosphorylation of Atg13 and FIP200 by ULK1 and the entire
complex is relocated to the phagophore (21, 22). Activation of
Atg13 and FIP200 is required for the formation of the phagophore
under starvation conditions whereas ULK1 appears to be dis-
pensable (23). It remains to be seen whether the role of ULK1
in autophagy extends beyond its kinase function. The ULK1
ortholog in yeast, Atg1, interacts with the lipid membranes of
FIGURE 2 | Initiation via ULK1 complex: the regulatory complex
mTORC1 represses autophagy activation in nutrient rich conditions.
mTORC1 phosphorylates a serine residue on ULK1 to prevent it interacting
with positive regulators of autophagy induction. Atg13 activation is similarly
repressed by mTORC1-mediated phosphorylation. Glucose or amino acid
starvation results in the repression of mTOR activation. Consequently,
ULK1 phosphorylates both FIP200 and Atg13, resulting in the activation of
downstream autophagy effector proteins.
FIGURE 1 | Basic steps involved in mammalian macroautophagy.
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vesicles via its C-terminal domain, suggesting that it may recruit
the first vesicles to the phagophore assembly site (PAS) following
autophagy induction (24).
The second step in the autophagic process involves the forma-
tion of a phospholipid bilayer membrane known as the isolation
membrane or phagophore. This early membrane structure is the
precursor to the mature autophagosome membrane. The origin of
the autophagosome precursor, known as the “phagophore,” is an
aspect of autophagy about which little is currently known. Con-
siderable divergence in the formation of the phagophore between
mammalian and yeast cells exists. In S. cerevisiae autophago-
some formation begins at a defined location known as the PAS
(25). The PAS is associated with the yeast vacuole and the
resultant autophagosome eventually fuses with the vacuole and
the autophagosomal contents are degraded. In contrast, mam-
malian autophagosomes may instead form at multiple locations
throughout the cell (26).
Autophagosome formation has been observed associated with
various membranous structures such as the ER, plasma mem-
brane, Golgi apparatus, and mitochondria (27–30). A grow-
ing body of evidence supports the ER as a starting point for
phagophore formation in mammalian cells. Axe et al. identified
a unique compartment of the ER involved in autophagosome
formation marked by the presence of phosphatidylinositol-(3)-
phosphate (PI (3)P)-binding double FYVE-containing protein
(DFCP1), since termed the omegasome (27). Visualization of the
DFCP1+ omegasome shows the formation of the phagophore sur-
rounded by the cradle-like omegasome. Furthermore, the two
membranes are directly connected suggesting that perhaps the
phagophore arises from the ER (27, 31, 32). Further experiments
are required to determine the precise origins of the initial isola-
tion membrane and the functional significance of the DFCP1+
omegasome in autophagy.
An early event in the formation of the phagophore membrane is
likely to be the recruitment of PI(3)P to the membrane. Although
its precise role of PI(3)P in autophagy is unknown, it is a key
requirement for the recruitment of many of the downstream
effector proteins critical for extension and completion of the
autophagosomal membrane (33). The autophagosome membrane
is enriched with PI(3)P, particularly at the elongating tips of the
phagophore (34, 35). Localization to these points most likely serves
to recruit FYVE, PX, and WD-40 domain-containing autophagy
effectors for efficient assembly of the phagophore membrane. Gen-
eration of PI(3)P requires the kinase activity of class III PI(3)K
complexes to the phagophore (Figure 3). The most prominent
of this class of PI(3)K complex in mammalian autophagy is the
FIGURE 3 | PI(3)K-mediated vesicle nucleation:The activated ULK1
complex translocates to the phagophore formation site. In
starvation-induced autophagy this is likely to be adjacent to the ER initially but
ULK1 also associates with the phagophore. ULK1 complex activation results
in the translocation of the Beclin 1 lipid kinase complex to the phagophore
assembly site. Beclin 1 acts as a scaffold protein forming a complex with
Vps34 PI(3)K, its Vps15 subunit and Atg14. Similarly to orthologs yeast
proteins the mammalian Vps15 subunit is predicted to interact with lipid
membranes thereby tethering Vps34 to vesicles. Vps34 is the subunit of the
Beclin1 lipid kinase complex that catalyzes the phosphorylation of the 3
region of the inositol head group of phosphatidylinositol to generate PI(3)P.
The transmembrane Atg9 is found localized to post-Golgi vesicles but is
depicted on the same vesicle as the Beclin 1 complex for convenience. The
extent to which vesicular Beclin 1 and Atg9 overlap in their distribution is
unclear. The inclusion of the Atg14 protein recruits the Beclin 1 complex
specifically to the ER. This may serve two functions in assembly of the
autophagosome. The first and perhaps most crucial function is the generation
of PI(3)P at the omegasome and/or phagophore, which is essential for the
recruitment of many effector proteins required for autophagosome assembly.
PI(3)P production results in an accumulation of PI(3)P-binding protein DFCP1
at the omegasome membrane, the functional significance of which is
unknown. ER-associated WIPI proteins, WIPI1 and WIPI2 also bind PI(3)P and
are essential in the transition from omegasome to the double membrane
phagophore.
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complex consisting of beclin 1 (BCN1), the PI(3)K Vps34, its regu-
latory subunit Vps15, and Atg14 (36). Following the localization of
the ULK1 complex to the phagophore the next major step involves
the recruitment of the beclin 1 complex to the phagophore. Atg14
is of critical importance in directing the beclin 1-Vps34 kinase to
the phagophore due to its ability to interact with the ER mem-
brane (35, 37, 38). Since the phagophore appears to form in close
proximity to the ER membrane it is possible that the omegasome
promotes autophagosome formation by recruiting PI(3)K activity
to the adjacent membrane.
The kinase activity of Vps34 is also required for the activation
of another key step in the process of autophagosome formation.
WD-40 repeat domain-containing phosophoinositide interacting
proteins (WIPI) WIPI1 and WIPI2 (mammalian orthologs of the
yeast Atg18) may be found localized to the ER, plasma mem-
brane, and Golgi (39). WIPI1 and WIPI2 have also been observed
in close proximity to DFCP1 suggesting that it is recruited to
the omegasome or phagophore via its PI(3)P-binding domain
(40–42). Cells deficient in WIPI2 displayed defective DFCP1+
omegasome formation in response to starvation (42). WIPI1 and
WIPI2 are both later found localized to the LC3+ autophago-
somal membrane supporting the theory that WIPI1 and WIPI2
regulate the transition of the omegasome to phagophore (39). In
yeasts the WIPI ortholog, Atg18, interacts with both Atg2 and
Atg9, and is involved in retrograde movement of Atg9 from the
autophagosome (43). Orthologs of the yeast Atg2, mammalian
Atg2A and Atg2B are known to be essential for the completion
of the autophagosome in mammalian autophagy but their role is
still poorly understood (44). However, Atg9 has been the subject
of considerable investigation due to its unique transmembrane
localization and its role in the early stages of autophagosome
formation. Interaction between Atg9 and the phagophore mem-
brane appears to be transient yet essential for autophagy (45, 46).
Atg9 is likely carried on Golgi-derived secretory vesicles or on
endosomes, which are trafficked between the phagophore and the
trans-Golgi network (TGN) and endosomes (29, 47). The traf-
ficking of Atg9+ vesicles from other membranous organelles and
the essential role of Atg9 in autophagosome formation has led
to speculation that these vesicles may transport lipids vital for
extending the phagophore (48). An additional role for Atg9 has
been suggested by study into autophagy-induced by Salmonella
typhimurium. Kageyama et al. observed that Atg9 is required for
recruitment of the PI(3)K complex to the Salmonella-containing
vacuole and formation of the autophagosome (49). The observed
absence of PI(3)P-binding WIPI1 from membrane-bound bac-
teria suggested that WIPI1 may instead function downstream of
Atg9.
Elongation of the phagophore/early autophagosome mem-
brane in yeasts requires the protein Atg8. In mammals there have
been four Atg8 orthologs identified; microtubule-associated pro-
tein 1 light chain 3 (LC3), GABARAP, GATE-16, and Atg8L. Of
these four proteins LC3 is the best characterized in autophagy.
LC3 is unique in that, once converted from LC3-I to its lipidated
form (LC3-II) it is incorporated into the elongating autophago-
some and remains associated with the autophagosome even after
the dissociation of other Atg proteins. Thus LC3-II serves as an
accepted and widely used marker of autophagosomes (50). For
the efficient processing of LC3 from pro-LC3 to LC3-II, eukary-
otes have evolved a pair of ubiquitinylation-like reactions. The
first ubiquitinylation-like reaction catalyzes the formation of an
Atg16L1-Atg5-Atg12 complex (Figure 4) (51). The Atg7 homod-
imer forms a thioester bond between a cysteine residue within
the Atg7 active site and the Atg12 C-terminal glycine, simi-
lar in its mechanism to an ubiquitin E1-like activating enzyme.
The Atg12 C-terminal thioester bond is subsequently transferred
from Atg7 to Atg10 (E2-like enzyme). Atg10 catalyzes the for-
mation of an isopeptide bond which covalently links Atg5 to
Atg12. Atg16L1 binds non-covalently to Atg5 and enables the
formation of a Atg16L1-Atg5-Atg12 tetrameric complex through
interaction between Atg16L1 coiled-coil domains (52). The second
ubiquitinylation-like reaction involves the conversion of lipidated
LC3-II from its precursor form (Figure 5). The protease Atg4
cleaves the C-terminal region of pro-LC3 immediately after the
precursor is synthesized, releasing a soluble LC3-I into the cytosol
(53). The proteolytic action of Atg4 exposes a C-terminal glycine
residue which allows for interaction with the active site of Atg7
homodimers. Atg7 functions as a E1-like enzyme in this second
ubiquitinylation-like reaction also, this time however, transfer-
ring the LC3-I C-terminal domain to Atg3 (54). Atg3 (E2-like
enzyme) catalyzes the conjugation of LC3-I to the lipid phos-
phatidylethanolamine (PE) (55). Lipidation of LC3 is a critical step
in the formation and completion of the autophagosomal mem-
brane (56). The Atg16L1 complex may facilitate the lipidation and
incorporation of LC3 into the expanding autophagsomal mem-
brane. The Atg16L1-Atg5-Atg12 conjugate interacts with Atg3 and
may also lipidate LC3 independent of Atg3 (57). The Atg16L1
complex may therefore assist in ensuring LC3 conversion occurs
in close proximity to the membrane to accelerate autophagosome
formation.
The final stage in autophagy involves the fusion of endo-
somes and lysosomes with the mature autophagosome resulting
in degradation and recycling of its contents. Dissociation of Atg
proteins from the autophagosomal membrane may be required
before fusion with endosomes or lysosomes can begin. Part of
this process involves the depletion of PI(3)P associated with the
autophagosome. Defective PI(3)P phosphatase activity prevents
the dissociation of Atg proteins from the autophagosome and
results in an accumulation of completed autophagosomes in the
yeast cytoplasm (58). In mammals the fusion of endosomes with
the autophagosome forms a multivesicular body (MVB), which
appears to be an important process in the degradation of select
protein accumulations (59). Fusion of endosomes is mediated
by various proteins involved in endosomal trafficking including
ESCRT, SNARE, and Rab7 proteins (59–61). The protein encoded
by the ultraviolet radiation resistance-associated gene (UVRAG)
regulates Rab7-mediated endosomal trafficking by forming a
unique complex with beclin 1-Vps34-Vps15 (62). The associa-
tion of UVRAG with beclin 1 recruits the Vps kinase complex to
the membrane, thereby activating Rab7 promoting endosomal and
lysosomal fusion with the autophagosome. Recent evidence sug-
gests that LC3-II bound to the autophagosome membrane may
also be a key element in Rab7-mediated endosomal/lysosomal
fusion (63). Following lysosomal fusion, the inner autophagoso-
mal membrane and its contents are degraded and amino acids
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FIGURE 4 | Atg5-Atg12 complex conjugation system. Agt12 is
conjugated to Atg5 and Atg16L1 via a ubiquitinylation-like process.
Homodimeric Atg7 functions as an ubiquitin-activating (E1)-like enzyme,
activating Atg12 through the formation of a thioester bond between the
Atg7 active site cysteine and the Atg12 C-terminal glycine. Atg7 transfers
the activated Atg12 to the E2-like enzyme Atg10 via the C-terminal thioester
linkage. Atg10 catalyzes the formation of an irreversible isopeptide bond
between the Atg12 C-terminal glycine and Atg5. After the formation of the
Atg5-Atg12 conjugate, Atg16L1 associates with the complex, binding
non-covalently with Atg5. Interaction between Atg16 coiled-coil domains on
adjacent Atg5-Atg12-Atg16L1 conjugates results in the formation of
tetrameric complexes.
transported into the cytoplasm. In contrast to yeasts which uti-
lize Atg proteins such as Atg15 and Atg22 in the degradation
and recycling process, to our knowledge no such equivalents have
yet been discovered in mammalian autophagy. Instead common
lysosomal proteases such as cathepsins B, D, and L are required
for degradation of autophagosomal contents (64, 65). Recycling
of nutrients from the degraded autophagosomal contents are
presumably recycled via lysosomal permeases transferred to the
autophagosomal membrane during lysosomal fusion. However, a
recent study has identified a mammalian transmembrane lyso-
somal permease, Spinster, involved in transporting carbohydrate
from the autophagosome into the cytoplasm (66). Of particu-
lar interest is the role of Spinster in the termination of autophagy,
which may be marked by autophagic lysosome reformation (ALR),
during which functional lysosomes are reconstituted from the
autophagosome (67). Spinster is necessary for the reactivation of
mTOR and the subsequent reformation of functional lysosomes
from the autophagolysosome (66). The role of other lysosomal
efflux transporters in signaling the termination of autophagy and
its potential significance in human disease may be a promising
area for future study.
AUTOPHAGY GENES INVOLVED IN INTESTINAL
HOMEOSTASIS AND SUSCEPTIBILITY TO IBD
To date a number of polymorphisms in a wide range of genes have
been identified as risk factors predisposing an individual to the
development of IBD. Numerous genome-wide association scan-
ning (GWAS) studies have attempted to identify the genes con-
tributing to the development of CD. Two of the most prominent
associations with CD have been autophagy-related gene 16-like
(ATG16L1) and NOD2 (68–71). The identification of an ATG16L1
polymorphism as a genetic risk factor for CD by GWAS studies
has drawn attention to the potential importance of autophagy as
an etiologic factor in IBD. Since the identification of ATG16L1 as
a risk factor for CD, more recent GWAS studies have implicated a
number of other autophagy-related genes in susceptibility to CD
(summarized in Table 1). Of particular interest in the etiology
of CD are the genes which link innate immunity with autophagy
such as IRGM and NOD2. It is noteworthy that autophagy appears
to play a lesser role in UC. ER stress has been implicated in the
development of UC and as such a strong association with XBP1
mutants and UC exists. However, one of the mechanisms which
may be employed to relieve ER stress is autophagy, and as such
defective XBP1 affect autophagy induction in UC. However, lim-
ited overlap in susceptibility genes between IBD does exist, with
the autophagy-regulating gene, PTPN2 associated with both CD
and UC (72).
ATG16L1
Several GWAS studies have linked polymorphisms in the gene
encoding the mammalian ortholog of Atg16 (ATG16L1) to
susceptibility to CD (69, 73). Functional ATG16L1 is crucial
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FIGURE 5 | LC3-PE conjugation system. Atg4 cleaves the carboxyl terminal
region of LC3 immediately after synthesis, generating a soluble LC3-I which
now possesses a C-terminal glycine required for further modifications.
Homodimeric Atg7 functions similarly to ubiquitin-activating (E1) enzymes and
binds the LC3-I C-terminal exposed by Atg4 before recruiting Atg3 via its
N-terminal domain. LC3-I is transferred to the Atg3 enzyme during the
Atg3-Atg7 interaction. Atg7 dissociates from the LC3-I complex. LC3-II is
formed when LC3-I is conjugated to the lipid phosphatidylethanolamine (PE)
in a reaction catalyzed by Atg3. Binding of the Atg5-Atg12-Atg16L1 to Atg3
enhances the lipidation of LC3-I. The ability of the Atg5-Atg-12 complex to
bind PE already inserted into the isolation membrane ensures that newly
converted LC3-II is incorporated into the elongating isolation membrane.
Unlike the formation of the Atg5-Atg12 complex, the conversion of LC3-I to
LC3-II is reversible. Atg4 cleaves PE from LC3-II and LC3 is recycled.
Table 1 | Genetics of aberrant autophagy in IBD.
Gene Function Polymorphism and association with IBD
ATG16L1 Required for assembly of the autophagosome SNP encoding T300A substitution conferring susceptibility to CD
(rs2241880) (67, 68, 72)
NOD2 Initiator of autophagy in response to MDP; recruits ATG16L1 to
site of bacterial entry
Three SNPs associated with susceptibility to CD (rs2066844,
rs2066845, and rs2066847) (69, 70, 115)
XBP1 Leucine-rich repeat transcription factor associated with
autophagosome maturation
Several polymorphisms associated with CD (93, 116, 117)
IRGM Small anti-microbial GTPase that regulates autophagosome
formation
Two SNPs (1 exonic; rs10065172 and 1 deletion upstream of IRGM :
rs13361189) associated with CD (67, 88, 90, 118)
LRRK2 Leucine-rich repeat kinase associated with autophagosome
maturation
Association with CD (69, 97)
ULK1 Kinase that forms part of a key autophagy-initiation complex SNP associated with CD (94)
PTPN2 Regulates formation of the autophagosome in response to IFN-γ
and TNF-α
Two SNPs (rs2542151 and rs1893217) with modest association with
CD (67, 69, 70, 88), and UC (71)
for the induction of autophagy. Atg5-Atg12 protein conjugates
interact with Atg16L1 to form a high molecular weight pro-
tein complex essential for the elongation of the autophagosomal
membrane (52, 74). Insight into the potential importance of
ATG16L1 and autophagy in the pathogenesis of CD were revealed
by the generation of the following two experimental models.
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Atg16L1 deficiency
Due to the importance of autophagy in neonatal survival, very
few mice bred with a deficiency in Atg16L1 survived 1 day post-
partum (75). To examine the effect of an otherwise lethal Atg16L1
deficiency, two experimental approaches have been used. The first
involves the creation of chimeric mice, in which fetal liver cells
from Atg16L1-deficient mice were transferred to lethally irradi-
ated wild-type mice. In contrast to wild-type embryonic cells,
fibroblasts deficient in functional Atg16L1 failed to respond to
starvation with autophagosome formation (75). Furthermore,
Atg16L1-deficient fetal liver chimeric mice displayed normal bac-
terial colonization of the colon and no indication of spontaneous
colitis (75). However, Atg16L1-deficient chimeric mice adminis-
tered 5% DSS for 7 days exhibited a marked exacerbation of colitis
with reduced survival.
ATG16L1 hypomorphic mice
The second model utilized gene trap mutations of the ATG16L1
gene resulting in hypomorphic gene expression. In addition
to defective autophagosome assembly, ileal Paneth cells from
ATG16L1 hypomorphic mice displayed abnormal exocytosis and
secretion of anti-microbial peptides (76). The morphological
abnormalities in Paneth cells generated by this mutation were
similar to that obtained by targeted deletion of epithelial ATG5
(76). Apart from aberrant Paneth cell morphology, no histologi-
cal differences could be observed between the ileum of ATG16L1
knockouts and wild-type mice. The results of these experiments
strongly suggest that Paneth cells in particular are vulnerable to
defects in autophagy.
The validity of these murine models is supported by observa-
tions in human patients with CD. Defective Paneth cell function
in Atg16L1-deficient mice resembles the abnormalities in Paneth
cell secretory granule exocytosis in patients with CD (76, 77).
The function of autophagy mechanisms including Atg16L1 may
therefore to extend to cytokine secretion. Pro-inflammatory stim-
uli such as lipopolysaccharide and muramyl dipeptide (MDP)
are capable of enhancing IL-1β transcription, thereby increas-
ing levels of intracellular pro-IL-1β (78). The major mechanism
through which IL-1β regulation occurs is at the post-translational
level, cleavage of pro-IL-1β to the biologically active IL-1β. Cleav-
age occurs through the activity of the enzyme caspase-1, which
itself must first be activated by the inflammasome protein com-
plex. The greatly enhanced IL-1β secretion in Atg16L1-deficient
macrophages suggests that autophagy plays a role in modulating
immune responses from these cells. Indeed autophagy has been
demonstrated to regulate IL-1β secretion in vitro.
Recently, Lee et al. (79) showed that increased MDP-induced
IL-1β secretion from Atg16L1-deficient PBMC was greatly dimin-
ished by type III PI3K autophagy inhibitors. Another more recent
study has revealed an additional autophagy-dependent regula-
tory mechanism in IL-1β signaling. The protein p62 is thought
to promote the secretion of IL-1β via the activation of TRAF6,
an element of the IL-1β receptor signaling pathway, upstream of
NF-κB (79). Degradation of p62 via Atg16L1-mediated autophagy
would therefore be expected to act as a negative regulator of IL-
1β signal transduction. A reduction in functional Atg16L1, such
as may be expected to occur with the CD-associated ATG16L1
allele, may therefore lead to cellular hyper responsiveness to IL-1β
secretion.
It seems plausible that autophagy mechanisms are required for
secretion of Paneth cell granules via a non-conventional secre-
tory pathway. Patients with CD carrying the ATG16L1 T300A
risk alleles also displayed increased numbers of LC3+ autophago-
somes within Paneth cells (77). Increased numbers of autophago-
somes would suggest that either formation of autophagosomes
is increased or alternatively, lysosomal fusion is inhibited and as
a result autophagosomes accumulate in the cytoplasm. Defective
ATG16L1 may therefore inhibit the completion of the autophago-
some membrane by unknown mechanisms. However, Thachil and
colleagues reported that neither the common ATG16L1 nor IRGM
polymorphisms associated with CD, appeared to be responsible for
the increased numbers of autophagosomes in Paneth cells (77).
It is possible that other ATG16L1 variants exist, in the coiled-
coil domain region for example, which would prevent efficient
autophagosome degradation (80). Further characterization of the
CD-associated ATG16L1 mutant proteins will likely explain the
conflicting data. Overall, evidence still suggests that ATG16L1
mutation results in a consequent reduction in lysozyme secretion.
Therefore defective autophagy could conceivably reduce the anti-
microbial effectiveness of the intestinal barrier, permitting greater
microbial invasion into the mucosa.
Exposure to the microbiota or an inappropriate response to the
microbiota of the intestine is widely considered to be a causative
factor in IBD. In DSS-induced colitis for example, inflammation
may be improved by antibiotic therapy (81). Other experimental
models of colitis such as T cell transfer and IL-10−/− colitis do
not display overt inflammation when housed in sterile conditions.
ATG16L1 hypomorphic mice, when rederived into a sterile barrier
facility, displayed morphologically normal Paneth cells (82). The
evidence for a microbial etiological factor was strengthened fur-
ther by inoculating mice with a murine norovirus (MNV). The
CR6 strain causes persistent gastrointestinal infections in mice.
Inoculation of ATG16L1 hypomorphic mice with the CR6 strain
reproduced the Paneth cell abnormalities observed in mice housed
under less stringent conditions. Inoculation of a similar strain
(CW3) that did not result in persistent infection, also failed to
induce alteration to Paneth cell morphology. Interestingly when
infected hypomorphic mice were challenged with a moderately
high dose of DSS the resultant pathology was strikingly similar to
CD. These mice exhibited transmural inflammation of the anorec-
tal junction accompanied by mucosal lymphoid aggregates, thick-
ening of the muscularis propria, and subserosal fibrosis (82). In
addition to colonic inflammation CR6-infected Atg16L1-deficient
mice also displayed ileal inflammation not observed with DSS
challenge in wild-type mice. Inflammation of the ileum and colon
could be attenuated by treatment with antibiotics, tumor necrosis
factor-α (TNF-α), or interferon-γ (IFN-γ) blocking therapy, all of
which can be used effectively in symptomatic treatment of CD.
The experimental evidence suggests that chronic viral infection,
when combined with epithelial injury and defective autophagy,
may be the prelude to IBD.
The individual contribution of reduced functional Atg16L1 to
inflammation in the MNV-DSS model remains to be elucidated.
It is known that macroautophagic mechanisms are involved in
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immunity. It is possible that persistent enteric infections caused by
some pathogens are poorly limited when macroautophagic mecha-
nisms are deficient. However, alternative autophagy pathways may
compensate in the absence of functional macroautophagy.
NOD2
The nucleotide-binding oligomerization domain-containing
(NOD) pattern recognition receptors NOD1 and NOD2 are key
elements in immunity against intracellular pathogens. Cytoplas-
mic NOD1 and NOD2 recognize cell wall components of invasive
bacteria such as Shigella flexneri and Listeria monocytogenes. The
association of NOD2 variants with susceptibility to CD has high-
lighted the role of autophagy in innate immunity. The 3020insC
SNP (rs2066847) frameshift mutation in NOD2 is the most preva-
lent of the three identified NOD2 risk variants in patients with
CD (83). This mutation produces a Nod2 protein with a trun-
cated leucine-rich repeat (LRR) domain (84). The consequence
of this mutation is a loss of Nod2 functionality. Expression of
the 3020insC NOD2 variant in human cells resulted in attenu-
ated activation of NF-κB in response to MDP or peptidoglycan
(85). Not only is NF-κB activation abrogated but NOD2-mediated
xenophagy is also affected.
Both NOD1 and NOD2 appear to be critical components in
degradation of intracellular bacteria as part of a process referred
to as xenophagy. Nod2 acts a sensor for invasive intracellular
bacteria. As such Nod2 proteins have been show to accumulate
adjacent to the plasma membrane after cells are co-incubated with
S. flexneri (86). During S. flexneri infection, Nod2 appeared to
recruit Atg16L1 to the site of bacterial entry, adjacent the plasma
membrane. Mice expressing a frameshift mutation in Nod2 com-
parable to that of the 3020insC NOD2 SNP, exhibited marked
reduction in bacterial autophagy. Lymphoblasts homozygous for
the CD-associated ATG16L1 T300A allele obtained from patients
with CD, displayed a marked impairment in autophagosome for-
mation in response to the Nod2 agonist muramyl dipeptide (86).
It is unclear however, whether NOD2 mutation was present in the
same cells.
These findings suggest that the observed impairment in
autophagy in the intestine of patients with CD may occur as a
result of a combined defect in NOD2 and ATG16L1. It is notewor-
thy that the interaction between Nod2 and Atg16L1 appeared to
be unaffected by the ATG16L1 T300A substitution associated with
CD. However, this CD-associated Atg16L1 T300A variant was no
different substitution. However, these cells were not genotyped for
NOD2 mutations. These findings link NOD2 and ATG16L1, both
genes identified as risk factors for CD, in a shared pathway with
implications for the pathogenesis of CD.
The combined effect of these mutations may have profound
implications for innate immunity. The role of xenophagy in the
epithelium may be twofold. Firstly, degradation of intracellular
bacteria such as S. flexneri, Salmonella spp., and L. monocyto-
genes may reduce spread of these pathogens to uninfected cells.
However, the significance of autophagic clearance of intracellular
bacteria in limiting infections is unclear. Secondly, autophagy is
a key element in the processing of bacterial antigen for presen-
tation to T lymphocytes (87). It therefore seems plausible that
combined NOD2 and ATG16L1 mutations may result in impaired
adaptive immune responses to potentially pathogenic bacteria in
the gut. Conversely, the effect could conceivably result in inappro-
priate immune responses directed against bacterial commensals
that are normally tolerated in most people. The role for a defect
in innate immunity due to defective autophagy is strengthened
by the association of immunity-related GTPase family M (IRGM )
with CD.
IRGM
The small GTPase encoded by the human IRGM gene is thought
to direct autophagy in the degradation of intracellular pathogens.
So far, the only cellular proteins, which include Atg5 and Atg10,
that have been shown to interact with Irgm, are all involved in the
initial stages of autophagosome assembly (88). IRGM may limit
viral infection directly, through autophagic clearance, and indeed
a plethora of viral proteins target IRGM to disrupt autophagy
and promote viral replication (88). Perhaps more important is
the role of Irgm-mediated xenophagy in antigen processing and
presentation to generate effective adaptive immune responses
against bacteria invading the cell. Aside from antiviral immunity,
IRGM is a significantly limiting intracellular bacterial infections
has been well demonstrated. In mice, Irgm1 mediates IFN-γ-
induced autophagy required for the degradation of intracellu-
lar mycobacteria in macrophages (89). Similarly, human THP-1
macrophages overexpressing IRGM displayed decreased numbers
of intracellular adherent-invasive E. coli (AIEC) (90).
Early studies initially associated genetic variation in the IRGM
region with a susceptibility to CD (68). Further analysis revealed
three IRGM coding sequence variants, two of which could not be
associated with CD (91). The third IRGM risk variant identified
was a synonymous exonic SNP which does not result in alter-
ation to amino acid sequence or splicing sites (92). It is a deletion
polymorphism located upstream of the IRGM coding region. The
effect of this deletion polymorphism was cell type-dependent, and
in a colonic cell line actually increased IRGM expression compared
to the reference sequence used (92). Conversely, the aforemen-
tioned synonymous IRGM variant does in fact contain an altered
miRNA binding site (93). As a result, binding of regulatory miR-
196 is significantly impaired. To link a novel mechanism by which
IRGM expression is potentially dysregulated in CD, Brest et al.
analyzed the expression and localization of IRGM and miR-196 in
the colonic mucosa (93). Expression of IRGM within the colonic
epithelium is high under normal conditions, but is reduced dur-
ing inflammation while epithelial miR-196 expression increases. In
those patients with CD possessing the IRGM risk allele, no similar
reduction of IRGM occurred during active inflammation, presum-
ably due to inability of miR-196 to bind IRGM transcript. While
overexpression of IRGM results in increased autophagic activ-
ity during AIEC infection in human macrophages, epithelial cells
appear to respond differently (90). Increased autophagy in IRGM
overexpressing HEK293 cells appeared to encourage proliferation
of AIEC within autophagic vacuoles (93).
The functional consequence of IRGM overexpression in CD
remains unclear. Invasive species of E. coli, including AIEC, have
been observed to colonize the ileal mucosa of patients with
CD in greater numbers than normal controls (94, 95). Ineffi-
ciency in the clearance of invasive pathogens via autophagy in
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the intestinal mucosa of patients with CD may result in persistent
infection. This is supported by in vitro evidence suggesting that
impaired autophagy due to ATG16L1, NOD2 and IRGM mutation
in macrophages results in increased TNF-α and IL-6 secretion (90).
This could conceivably lead to exacerbation of the initial inflam-
mation and tissue injury allowing greater bacterial penetrance into
the mucosa in IBD.
PTPN2
Another gene recently identified as a risk factor in the development
of IBD is T cell protein tyrosine phosphate non-receptor type 2
(PTPN2). An SNP (rs2542151) upstream of the coding region
of PTPN2 has been associated with susceptibility to both CD
(70, 96) and UC (72). A second SNP (rs1893217) located within
intron 7 of the PTPN2 gene has also been associated with CD
(97, 98). The protein encoded by PTPN2 appears to be an impor-
tant negative regulator of signaling induced by pro-inflammatory
cytokines such as IFN-γ and IL-6 through its ability to dephos-
phorylate STAT1 and STAT3 in vitro (99). Ptpn2 knock-out mice
display severe defects in T cell development and from an early age
develop a lethal systemic inflammation, with high serum IFN-γ
and TNF-α (100–102). It is interesting to note that Ptpn2+ mice
display greater susceptibility to DSS than wild-type Ptpn2 mice,
suggesting that Ptpn2 negatively regulates inflammation (103).
Expression of PTPN2 in human T84 colonocytes is enhanced
by IFN-γ and TNF-α and accordingly PTPN2 mRNA levels are
increased in the inflamed mucosa of patients with CD (104, 105).
Since the link between defective autophagy and CD was identi-
fied, a potential role for PTPN2 in the regulation of autophagy
has also been investigated. Autophagy in wild-type T84 colonic
epithelial cells was induced by 24 h challenge with IFN-γ and
TNF-α, indicated by increased LC3B-II protein and LC3B-labeled
puncta (106). Knock-down of PTPN2 with specific siRNA in the
T84 cell line increased both mTOR phosphorylation and beclin 1
expression but simultaneously abrogated IFN-γ/TNF-α-induced
up-regulation of Atg5 and Atg7. Consequently, fewer larger LC3B-
labeled autophagosomes were observed following PTPN2 siRNA
knock-down, suggesting autophagosome formation was defec-
tive in PTPN2 deficient cells. To assess the contribution of the
rs2542151 PTPN2 variant to the autophagy impairment observed
in CD, Scharl et al. cultured lamina propria fibroblasts from the
colon of patients with CD. Stimulation of fibroblasts with both
IFN-γ and TNF-α increased autophagosome formation in wild-
type PTPN2 cells but this effect was absent in fibroblasts carrying
the PTPN2 CD-associated variant. The mechanisms by which
PTPN2 influences autophagy remain unclear. It has been suggested
that PTPN2 exerts its autophagy-promoting effect by repressing
mTOR activation via the EGFR-PI(3)K-AKT pathway following
its activation by IFN-γ and TNF-α (107).
The role of PTPN2 in coupling autophagy to pro-inflammatory
signaling may mean that PTPN2 is crucial in maintaining the
integrity of the intestinal barrier against pathogens. Scharl et al.,
showed that PTPN2 mutation or deficiency reduced the localiza-
tion of L. monocytogenes to autophagosomes in colonic epithelial
cells or fibroblasts (107). Whether the inclusion and/or clearance
of L. monocytogenes, or other invasive bacteria such as AIEC, in
autophagosomes in PTPN2 deficient cells is affected by IFN-γ or
TNF-α is yet to be determined. It is plausible therefore, that PTPN2
risk allele associated with CD, in combination with ATG16L1
and NOD2 mutants, permits greater persistence and spread of
intracellular pathogens, possibly contributing to a an increased
susceptibility to chronic inflammation (76, 82). Aside from the
role of PTPN2 in handling intracellular bacteria, PTPN2 may also
regulate the permeability of the intestinal barrier. Deficiency of
PTPN2 in T84 colonocytes increased the permeability of in vitro
epithelial monolayers to ionic and macromolecular flux. Increased
permeability was associated with a reduction in the expression of
occludin and zona-occludens-1, proteins typically associated with
epithelial tight junctions and key regulators of paracellular per-
meability. Recent evidence indicates a role for autophagy in the
regulation of cell–cell adhesion in human intestinal epithelial cells
stimulated with TNF-α. Pharmacological inhibition of TNF-α-
induced autophagy resulted in a reduction in the protein levels of
functional integrin β1 subunit (108). It is possible therefore that
autophagy is responsible for the removal and recycling of cellular
adhesion and tight junction proteins to facilitate regeneration of
the intestinal epithelium after acute inflammation. Determining
the full extent to which the CD-associated PTPN2 mutation and
the resultant autophagic defect contributes to chronic inflamma-
tion promises to yield valuable insight into the cellular physiology
of the intestine in both health and chronic disease.
XBP1
XBP1 is induced by ER stress and forms part of the unfolded pro-
tein response. One of the mechanisms used to regulate ER stress
induced by misfolded protein in the ER is autophagy (9). The iden-
tification of two XBP1 SNPs associated with CD and UC suggests a
link between IBD and the ER stress response (109). The two XBP1
variants were associated with hypomorphic XBP1 expression indi-
cating that the XBP1-mediated ER stress response by is defective
in patients with IBD.
Knock-out mice generated with an XBP1 deletion restricted to
the epithelial cells of the large and small intestine spontaneously
develop mild small intestinal inflammation. XBP1−/− Paneth cells
and to a lesser extent, goblet cells, undergo ER stress and conse-
quently undergo apoptosis. ER stress induced by XBP1 deletion
resulted in the depletion of Paneth cells in the small intestine
but not in the colon. However, XBP1−/− mice were vulnerable
to the induction of DSS-colitis. XBP1−/− mice displayed wast-
ing, rectal bleeding, mucosal erosion, and leukocyte inflammation
to a greater extent than did wild-type mice following 5 days of
4.5% DSS-administration (109). The consequence of hypomor-
phic XBP1 mutation in human IBD patients may therefore result
in impaired anti-microbial activity of Paneth cells. When com-
bined with the aforementioned ATG16L1 mutation in CD, defec-
tive XBP1 may further promote deleterious interactions with the
intestinal microbiota.
ULK1
Following the identification of autophagy-related genes such as
ATG16L1, NOD2, and IRGM a GWAS study was conducted to
identify additional risk factors among known autophagy genes.
An SNP in one these candidate genes, ULK1, was significantly
more frequent among patients with CD (110). Mammalian ULK1
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is homologous to the yeast Atg1 and its expression is ubiquitous in
most tissues. Together with Atg13, and FIP200, ULK1 is an essen-
tial member of a large protein complex whose activation initiates
the formation of the autophagosome. Autophagy induction under
conditions of high glucose abundance is repressed by interaction
between the autophagy regulator mTORC1 and ULK1, preventing
phosphorylation of the latter. During glucose starvation, ULK1
associates instead with AMPK, resulting in phosphorylation of
ULK1 and subsequent activation of autophagy (19, 111).
To best assess the biological function of ULK1 in vivo, a knock-
out mouse model was developed. Interestingly, ULK1−/− mice
exhibited normal autophagy in response to nutrient deprivation
suggesting that autophagy induction may still occur through Ulk2
signaling (112). The effect of ULK1 deletion in autophagy-induced
by other mechanisms however is yet to be determined. Invasion of
intestinal epithelial cells by bacterial pathogens such as AIEC may
be facilitated by impairment ULK, thereby promoting persistent
intestinal inflammation.
LRRK2
A polymorphism in the LRR kinase 2 gene (LRRK2) has been
associated with susceptibility to CD (70, 71). However, knowl-
edge of its contribution to the pathogenesis of IBD is limited.
The expression of LRRK2 is predominantly limited to mono-
cytes, dendritic cells, and lymphocytes (113). Furthermore LRRK2
expression can be up regulated in human PBMCs through IFN-γ
stimulation. Since IFN-γ dominates the mucosal cytokine pro-
file of patients with CD (114), it follows that LRRK2 expression
is higher in the inflamed mucosa of patients with CD relative
to non-inflamed regions (113). Although mutations in LRRK2
are known to confer risk of developing CD and also Parkin-
son’s disease, little evidence for its pathological function exists.
However, LRRK2 has relatively recently been implicated in the
regulation of autophagic pathways. LRRK2 co-localized with
autophagolysosomes and multivesicular bodies, both structures
formed by autophagy (115). In contrast to the other autophagy-
related genes associated with CD, LRRK2 appears to function as a
negative regulator of autophagy. Cells transfected with siRNA spe-
cific for LRRK2 exhibited enhanced basal autophagic activity, and
enhanced starvation-induced autophagy (115). In neuronal cells,
poorly controlled autophagy can result in autophagic stress. Neu-
ronal cells transfected with Parkinson’s disease-associated LRRK2
variants exhibited increased autophagic vacuole formation and
accumulation of protein aggregates (116). However, the mutations
associated with both Parkinson’s and CD is quite different. Muta-
tion in the LRRK2 kinase domain is associated with Parkinson’s
disease whereas the CD-associated LRRK2 variant results in less
functional protein (117). To assess the functional consequences
of the CD-associated mutant an experimental animal model was
utilized. C57BL/6 mice generated with Lrrk2 deficiency did not
develop spontaneous intestinal pathology (117). However, follow-
ing 8 days of DSS-administration, Lrrk2−/− mice exhibited more
severe colitis than mice with functional Lrrk. Notably, the pathol-
ogy induced by DSS in Lrrk2−/− mice was penetrated into the
muscle layer in a similar fashion to CD lesions. Liu et al. identified a
potential role for LRRK2 in regulating pro-inflammatory cytokine
secretion that likely contributes to the pathology of CD. However,
the effect of reduced LRRK2 on autophagy, and the mechanism
through which it occurs, remains to be investigated in this model.
The bulk of our understanding of autophagy mechanisms
is derived from experimental work performed using starvation-
induced autophagy as a model. It is assumed that the general
mechanisms of autophagy will be conserved for the most part
among autophagic processes induced by other stimuli. Naturally,
alternative autophagy pathways have been observed. For exam-
ple, the induction of autophagy by invasive bacteria may occur
through the mTORC1 pathway, or independently of this path-
way depending on bacterial species (17). It is noteworthy that
starvation-induced autophagy also contributes to host defense in
the event of infection with Shigella or Salmonella species (118).
The mechanisms for starvation-induced autophagy, which may be
somewhat non-specific and those regulating degradation of spe-
cific proteins and intracellular structures may also differ. Given
the involvement of autophagy in a broad spectrum of cellular
processes, it is likely that a wide range of receptors specific for
various proteins and organelles exists. Several receptors mediat-
ing the targeting of protein aggregates to the internal membrane
of the autophagosome have already been identified, perhaps the
most prominent being p62, and more receptors are likely to be
identified in the future (119).
CONCLUSIONS AND FUTURE DIRECTIONS
In this review, we have discussed in detail, the most important
gene pathways that have been shown to be important in mediating
autophagy in intestinal homeostasis. Research work in the area of
autophagy suggests that autophagy is not only an important player
in the pathogenesis of IBD but also a pathway that merges intesti-
nal innate immune sensing, microbial immune response, and ER
stress response. In all the above mentioned cellular responses
the intestinal epithelium, including the goblet cells and Paneth
cells, seems to orchestrate major signaling events. While current
studies are not conclusive about the inter-mingled pathways con-
necting innate immunity, autophagy, and ER stress, future studies
will unravel the common pathways. While the overall gene muta-
tions/polymorphisms associated with autophagy and their impor-
tance in predisposition to sub types of IBD are understood, the
exact triggers for defective autophagy are not understood yet. For
example, mice hypomorphic for Atg16L1 need a viral infection
trigger for inducing colitis-like pathology. Future research work
will focus on identifying specific environmental triggers that elicit
defective autophagy responses in disease.
While much of our understanding of autophagy mechanisms
comes from in vitro systems using either yeast or mammalian
cell lines, the significance of autophagy in pathology has mostly
been derived from experimental animal models. Using animals
to model defective autophagy mechanisms may however, intro-
duce an additional layer of complexity in our attempts to under-
stand cell type-specific defects in autophagy. Autophagy appears
to be ubiquitous through virtually all cell types and tissues and is
employed in a wide range of functions. The mammalian intesti-
nal mucosa includes several types of structural cells in addition
to a large concentration of resident immune cells. Functions such
as maintaining cytoplasmic stores of amino acids and removal
of defective mitochondria are likely to be employed by most
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cell types. However autophagy is also involved in more special-
ized processes which are restricted to certain types of other cells.
For example, autophagic mechanisms contribute to the secre-
tion of anti-microbial peptides and cytokines. Mutation of a
single autophagy gene may therefore be predicted to result in a
broad spectrum of pathological phenotypes across the various
cells of a single tissue. Considering the ubiquity of autophagy
throughout human tissues future attempts to modulate pathologic
immune responses caused in part by dysfunctional autophagy,
may be difficult. Investigating the contribution of dysfunctional
autophagy in each cell type of the intestinal mucosa may therefore
be necessary. Nevertheless, autophagy and its key role in regu-
lating homeostasis in the intestinal mucosa make it an attractive
target for exploring future avenues for therapy. Given the rapidly
growing interest in the role autophagy in human disease it seems
likely that the next few years will bring about a wealth of excit-
ing new research findings in IBD and autoimmune disease in
general.
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